Blinatumomab Injection

DRUG3 trials

Sponsors

Assistance Publique - Hôpitaux de Paris, Memorial Sloan Kettering Cancer Center, Liping Dou

Conditions

ALL (Acute B-Lymphoblastic Leukemia)Acute Lymphoblastic Leukemia, Adult B-CellB-ALLB-Cell Acute Lymphoblastic Leukemia, AdultB-cell Acute Lymphoblastic Leukemia

Phase 1

A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia

Not yet recruitingNCT07313852

Memorial Sloan Kettering Cancer CenterB-ALL, B-cell Acute Lymphoblastic Leukemia, B-Cell Acute Lymphoblastic Leukemia, Adult

Start: 2026-06-01End: 2029-01-01Target: 26Updated: 2026-06-16

Blinatumomab Combined With Low-dose DLI as Maintenance Therapy After Transplantation for B-ALL

RecruitingNCT07677878

Liping DouALL (Acute B-Lymphoblastic Leukemia)

Start: 2024-12-01End: 2028-12-01Target: 60Updated: 2026-07-01

Phase 2

Blinatumomab in High-risk B-cell Precursor Acute Lymphoblastic Leukemia

Active, not recruitingNCT03709719

Assistance Publique - Hôpitaux de ParisAcute Lymphoblastic Leukemia, Adult B-Cell

Start: 2018-10-20End: 2028-10-30Target: 95Updated: 2021-05-03